Rennova Health Inc (RNVA)
0.00
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Rennova Health Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | 35.47% |
| June 30, 2022 | 56.42% |
| March 31, 2022 | -20.11% |
| December 31, 2021 | 37.06% |
| September 30, 2021 | -19.55% |
| June 30, 2021 | -36.65% |
| March 31, 2021 | |
| December 31, 2020 | -171.2% |
| September 30, 2020 | -43.84% |
| June 30, 2020 | -29.00% |
| March 31, 2020 | -45.38% |
| December 31, 2019 | 5.51% |
| September 30, 2019 | 17.67% |
| June 30, 2019 | -15.25% |
| March 31, 2019 | 19.77% |
| December 31, 2018 | 19.84% |
| September 30, 2018 | 33.51% |
| June 30, 2018 | 28.02% |
| March 31, 2018 | -30.45% |
| December 31, 2017 | 84.76% |
| September 30, 2017 | 67.66% |
| June 30, 2017 | -182.2% |
| March 31, 2017 | 64.22% |
| December 31, 2016 | |
| September 30, 2016 | -637.8% |
| Date | Value |
|---|---|
| June 30, 2016 | 86.14% |
| March 31, 2016 | 69.97% |
| September 30, 2015 | 77.59% |
| June 30, 2015 | 75.93% |
| March 31, 2015 | 89.02% |
| December 31, 2014 | 80.85% |
| September 30, 2014 | 89.77% |
| June 30, 2014 | 71.88% |
| March 31, 2014 | 77.78% |
| December 31, 2013 | -85.71% |
| September 30, 2013 | 92.83% |
| June 30, 2013 | 93.33% |
| March 31, 2013 | 93.45% |
| December 31, 2012 | 28.00% |
| September 30, 2012 | 73.33% |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 | |
| December 31, 2010 | |
| September 30, 2010 | |
| June 30, 2010 | |
| March 31, 2010 | -49.56% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-171.2%
Minimum
Dec 2020
56.42%
Maximum
Jun 2022
-17.60%
Average
-19.55%
Median
Sep 2021
Gross Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 81.54% |
| IGC Pharma Inc | 65.20% |
| NovaBay Pharmaceuticals Inc | 48.70% |
| Protalix BioTherapeutics Inc | 15.54% |